Alzheimer and Cognitive Disorders Clinic
Dr. Serge Gauthier, MD, FRCPC
- Alzheimer's disease
(AD) is the most common type of dementia worldwide.
- The incidence and
prevalence of AD increases with age. It is estimated that more
people will be
affected by this condition, due to the increasing
longevity of our population.
- The Alzheimer and
Cognitive Disorders Clinic, a division of the McGill Centre
for Studies in
Aging, was founded in 1997 to establish a clinic
that specializes in AD and related
primary focus is to seek improved therapies, both
symptomatic and preventive, for AD and cognitive
disorders; to ensure long-term stabilization for patients;
and to enhance the quality of life for patients and
offers an expertise in the early diagnosis and
management of AD and cognitive disorders, including
vascular dementia and mild cognitive impairment.
treatment and follow-up are available, as well
as referral to other resources, such as help and support services, if desired.
is actively involved in cognitive research and
is recognized internationally as a clinical
trial site. Clinical trials (Phases II-IV) that
test the efficacy and safety of experimental drugs
for AD and other cognitive disorders are ongoing.
Gauthier, MD, FRCPC, neurologist and specialist
in the field, leads a team of experienced and
dedicated health professionals. Evaluations
are carried out in a friendly and inviting atmosphere
at a location which is easily accessible.
an appointment, please send your consultation request
fax or by mail to the following address:
Dr. Serge Gauthier
McGill Centre for Studies in Aging
6825 LaSalle Boulevard
Verdun (QC) H4H 1R3